Related Experiment Videos

Normal physical and mental development of 6-year-old children whose mothers were treated antenatally with

Acta Paediatrica Hungarica
|January 1, 1984
PubMed

Insights

Antenatal corticosteroid therapy, using prednisolone, showed no long-term adverse effects in children reexamined at age six. This confirms the safety of steroid prophylaxis for preventing infant respiratory distress syndrome (IRDS).

Area of Science:

  • Neonatal medicine
  • Pediatric development
  • Pharmacology

Background:

  • Antenatal steroid prophylaxis is crucial for preventing infant respiratory distress syndrome (IRDS).
  • Previous studies indicated benefits of antenatal steroid use.
  • Long-term safety of fetal exposure to steroids requires continued investigation.

Purpose of the Study:

  • To assess the long-term developmental outcomes of children exposed to antenatal prednisolone.
  • To reexamine children from a previous study at age six.
  • To determine if antenatal steroid prophylaxis poses any developmental hazards.

Main Methods:

  • Reexamination of 83 children treated with antenatal prednisolone and 57 controls at age six.
  • Assessment of physical growth (height, weight).
  • Evaluation of cognitive (IQ), psychosocial, neurological (EEG), ophthalmological, and audiological parameters.

Main Results:

  • Prednisolone-exposed children were slightly taller and heavier.
  • No significant differences were observed in IQ, psychosocial development, EEG, ophthalmology, or audiology between groups.
  • These findings suggest no detrimental long-term effects.

Conclusions:

  • Antenatal steroid prophylaxis with prednisolone does not appear to have long-term adverse effects on fetal development.
  • The benefits of IRDS prevention outweigh potential risks.
  • Continued monitoring supports the safety of this intervention.

Related Concept Videos